Search

Center for Scientific Review Closed Meeting Notices

The NIH Center for Scientific Review published a Federal Register notice announcing three closed meetings scheduled for April 28-30, 2026. The meetings will review grant applications for research programs including myocardial physiology, fellowships, and microplastic impacts. Meetings are closed under Federal Advisory Committee Act provisions to protect confidential grant information and personal data.

Center for Scientific Review Notice of Closed Meetings

The NIH Center for Scientific Review published a Federal Register notice announcing five closed meetings scheduled for April 29-30, 2026. The meetings, conducted virtually, will review grant applications including Claude D. Pepper Older Americans Independence Centers, Musculoskeletal/Skin/Oral Sciences PAR Panel, R21/R03 proposals, and neuroscience topics. Meetings are closed pursuant to the Federal Advisory Committee Act to protect confidential trade secrets and personal privacy.

TANF Work Participation Rate Calculation Changes

The HHS Children and Families Administration (ACF) has published a proposed rule to recalibrate the TANF work participation rate calculation, specifically modifying the caseload reduction credit methodology and prohibiting small checks in the calculation. The proposed changes would affect how states demonstrate compliance with federal work participation requirements under the Temporary Assistance for Needy Families program. Comments on the proposed rule are due by May 6, 2026.

STRATTERA Not Withdrawn for Safety or Effectiveness

The FDA determined that STRATTERA (atomoxetine hydrochloride) capsules at all dosage strengths (5mg through 100mg) were not withdrawn from sale for reasons of safety or effectiveness. This determination allows generic drug manufacturers to reference this finding in abbreviated new drug applications (ANDAs) without providing separate safety and effectiveness data.

E2B(R3) Data Standards for Postmarketing Safety Reports

FDA issued a notice proposing updated E2B(R3) data standards for electronic submission of postmarketing individual case safety reports to the FDA Adverse Event Monitoring System. The notice introduces new regional data elements and establishes an implementation schedule. Comments are due by October 1, 2026 (180 days from publication).

Notice of Public Data Asset Release Under OPEN Government Data Act

The Centers for Medicare & Medicaid Services (CMS) published a Federal Register notice announcing the release of public data assets under the OPEN Government Data Act. This notice informs the public that CMS has made certain data assets available in compliance with federal open data requirements. The action applies to healthcare providers, researchers, and other stakeholders who utilize CMS public data.

ACIP Charter Renewal Notice

The CDC renewed the Advisory Committee on Immunization Practices (ACIP) charter through April 2028. This routine administrative notice confirms the committee's continued operation under its federal advisory committee mandate. No new policy requirements or compliance obligations are established.

Reducing Bureaucracy and Burden for Children, Youth, and Family Programs

The Administration for Children and Families (ACF) within HHS has published a proposed rule to reduce bureaucratic burden and administrative requirements for programs serving children, youth, and families. The rule aims to streamline regulations affecting child welfare, foster care, youth development, and family support programs. Public comments are being accepted through May 6, 2026.

Hazardous Waste Worker Training OMB Comment Request 42 CFR Part 65

NIH/NIEHS published a corrected notice reopening the 30-day public comment period for an information collection request regarding hazardous waste worker training under 42 CFR Part 65. The original notice was published on March 18, 2026. This correction notice extends the comment period for stakeholders to provide feedback on the proposed training requirements for workers handling hazardous waste.

FDA CTP Complaint - Closed for Comments

The FDA Center for Tobacco Products filed a complaint (Docket FDA-2026-H-3161-0001) that was closed for comments on April 3, 2026. The complaint document was submitted through regulations.gov and is now archived. No documents are available for public viewing in this docket.